-
Ruxolitinib for patients with polycythemia vera who have had an inadequate response or are intolerant to hydroxyurea: a critical appraisal
Giovanni Barosi
Drug Evaluation: Clinical Investigation
-
Ruxolitinib for patients with polycythemia vera who have had an inadequate response or are intolerant to hydroxyurea: a critical appraisal
Giovanni Barosi
Drug Evaluation: Clinical Investigation
-
Ruxolitinib for patients with polycythemia vera who have had an inadequate response or are intolerant to hydroxyurea: a critical appraisal
Giovanni Barosi
Drug Evaluation: Clinical Investigation
-
Ruxolitinib for patients with polycythemia vera who have had an inadequate response or are intolerant to hydroxyurea: a critical appraisal
Giovanni Barosi
Drug Evaluation: Clinical Investigation
-
Ruxolitinib for patients with polycythemia vera who have had an inadequate response or are intolerant to hydroxyurea: a critical appraisal
Giovanni Barosi
Drug Evaluation: Clinical Investigation
-
Ruxolitinib for patients with polycythemia vera who have had an inadequate response or are intolerant to hydroxyurea: a critical appraisal
Giovanni Barosi
Drug Evaluation: Clinical Investigation
-
Ruxolitinib for patients with polycythemia vera who have had an inadequate response or are intolerant to hydroxyurea: a critical appraisal
Giovanni Barosi
Drug Evaluation: Clinical Investigation
-
Ruxolitinib for patients with polycythemia vera who have had an inadequate response or are intolerant to hydroxyurea: a critical appraisal
Giovanni Barosi
Drug Evaluation: Clinical Investigation
-
Treatment of albuminuria due to diabetic nephropathy: recent trial results
Edward J Horwitz & Jeffrey R Schelling
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of albuminuria due to diabetic nephropathy: recent trial results
Edward J Horwitz & Jeffrey R Schelling
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of albuminuria due to diabetic nephropathy: recent trial results
Edward J Horwitz & Jeffrey R Schelling
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of albuminuria due to diabetic nephropathy: recent trial results
Edward J Horwitz & Jeffrey R Schelling
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of albuminuria due to diabetic nephropathy: recent trial results
Edward J Horwitz & Jeffrey R Schelling
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of albuminuria due to diabetic nephropathy: recent trial results
Edward J Horwitz & Jeffrey R Schelling
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of albuminuria due to diabetic nephropathy: recent trial results
Edward J Horwitz & Jeffrey R Schelling
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of albuminuria due to diabetic nephropathy: recent trial results
Edward J Horwitz & Jeffrey R Schelling
Review: Clinical Trail Outcomes: Clinical Investigation
-
Results published on Phase II clinical trial for dengue vaccine
News and Views: Clinical Investigation
-
Results published on Phase II clinical trial for dengue vaccine
News and Views: Clinical Investigation
-
Results published on Phase II clinical trial for dengue vaccine
News and Views: Clinical Investigation
-
Results published on Phase II clinical trial for dengue vaccine
News and Views: Clinical Investigation
-
Results published on Phase II clinical trial for dengue vaccine
News and Views: Clinical Investigation
-
Results published on Phase II clinical trial for dengue vaccine
News and Views: Clinical Investigation
-
Results published on Phase II clinical trial for dengue vaccine
News and Views: Clinical Investigation
-
Results published on Phase II clinical trial for dengue vaccine
News and Views: Clinical Investigation
-
Personalized medicine in rheumatoid arthritis: rationale & clinical evidence
BC Visser, IH Brinkman, MAFJ van de Laar
Review: Clinical Trail Outcomes: Clinical Investigation
-
Personalized medicine in rheumatoid arthritis: rationale & clinical evidence
BC Visser, IH Brinkman, MAFJ van de Laar
Review: Clinical Trail Outcomes: Clinical Investigation
-
Personalized medicine in rheumatoid arthritis: rationale & clinical evidence
BC Visser, IH Brinkman, MAFJ van de Laar
Review: Clinical Trail Outcomes: Clinical Investigation
-
Personalized medicine in rheumatoid arthritis: rationale & clinical evidence
BC Visser, IH Brinkman, MAFJ van de Laar
Review: Clinical Trail Outcomes: Clinical Investigation
-
Personalized medicine in rheumatoid arthritis: rationale & clinical evidence
BC Visser, IH Brinkman, MAFJ van de Laar
Review: Clinical Trail Outcomes: Clinical Investigation
-
Personalized medicine in rheumatoid arthritis: rationale & clinical evidence
BC Visser, IH Brinkman, MAFJ van de Laar
Review: Clinical Trail Outcomes: Clinical Investigation
-
Personalized medicine in rheumatoid arthritis: rationale & clinical evidence
BC Visser, IH Brinkman, MAFJ van de Laar
Review: Clinical Trail Outcomes: Clinical Investigation
-
Personalized medicine in rheumatoid arthritis: rationale & clinical evidence
BC Visser, IH Brinkman, MAFJ van de Laar
Review: Clinical Trail Outcomes: Clinical Investigation
-
A time for hope - new metastatic melanoma agent astounds at the ASCO
News and Views: Clinical Investigation
-
A time for hope - new metastatic melanoma agent astounds at the ASCO
News and Views: Clinical Investigation
-
A time for hope - new metastatic melanoma agent astounds at the ASCO
News and Views: Clinical Investigation
-
A time for hope - new metastatic melanoma agent astounds at the ASCO
News and Views: Clinical Investigation
-
A time for hope - new metastatic melanoma agent astounds at the ASCO
News and Views: Clinical Investigation
-
A time for hope - new metastatic melanoma agent astounds at the ASCO
News and Views: Clinical Investigation
-
A time for hope - new metastatic melanoma agent astounds at the ASCO
News and Views: Clinical Investigation
-
A time for hope - new metastatic melanoma agent astounds at the ASCO
News and Views: Clinical Investigation
-
Data and safety monitoring boards of randomized trials: evolving principles and practical suggestions
Charles H Hennekens,David DeMets4
Review Article: Clinical Investigation
-
Data and safety monitoring boards of randomized trials: evolving principles and practical suggestions
Charles H Hennekens,David DeMets4
Review Article: Clinical Investigation
-
Data and safety monitoring boards of randomized trials: evolving principles and practical suggestions
Charles H Hennekens,David DeMets4
Review Article: Clinical Investigation
-
Data and safety monitoring boards of randomized trials: evolving principles and practical suggestions
Charles H Hennekens,David DeMets4
Review Article: Clinical Investigation
-
Data and safety monitoring boards of randomized trials: evolving principles and practical suggestions
Charles H Hennekens,David DeMets4
Review Article: Clinical Investigation
-
Data and safety monitoring boards of randomized trials: evolving principles and practical suggestions
Charles H Hennekens,David DeMets4
Review Article: Clinical Investigation
-
Data and safety monitoring boards of randomized trials: evolving principles and practical suggestions
Charles H Hennekens,David DeMets4
Review Article: Clinical Investigation
-
Data and safety monitoring boards of randomized trials: evolving principles and practical suggestions
Charles H Hennekens,David DeMets4
Review Article: Clinical Investigation